Childhood asthma and chronic obstructive pulmonary disease: Outcomes until the age of 50

Current Opinion in Allergy and Clinical Immunology

Volumn 15, Issue 2, 2015, Pages 169-174

  Tai, Andrew ^a,b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

asthma; chronic obstructive pulmonary disease; longitudinal study

Indexed keywords

AGE; AIRWAY REMODELING; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; GENOTYPE; HUMAN; LONGITUDINAL STUDY; LUNG FUNCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; ADOLESCENT; ADULT; CHILD; COMPLICATION; FEMALE; INFANT; MALE; MIDDLE AGED; PRESCHOOL CHILD; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ADOLESCENT; ADULT; AGE FACTORS; ASTHMA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 84923857634     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000146     Document Type: Article

References (59)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3:e442.
2. Sluiter HJ, Koeter GH, de Monchy JG, et al. The Dutch hypothesis (chronic nonspecific lung disease) revisited. Eur Respir J 1991; 4:479-489.
3. King ME, Mannino DM, Holguin F. Risk factors for asthma incidence: a review of recent prospective evidence. Panminerva Med 2004; 46:97-110.
4. Lamprecht B, McBurnie MA, Vollmer WM, et al. COPD in never smokers. Chest 2011; 139:752-763.
5. Lundback B, Lindberg A, Lindstrom M, et al. Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003; 97:115-122.
6. Trupin L, Earnest G, San Pedro M, et al. The occupational burden of chronic obstructive pulmonary disease. Eur Respir J 2003; 22:462-469.
7. Dennis RJ, Maldonado D, Norman S, et al. Woodsmoke exposure and risk for obstructive airways disease among women. Chest 1996; 109:115-119.
8. Pé rez-Padilla R, Regalado J, Vedal S, et al. Exposure to biomass smoke and chronic airway disease in Mexican women. A case-control study. Am J Respir Crit Care Med 1996; 154 (3 pt 1):701-706.
9. Sood A, Petersen H, Blanchette C. Wood smoke-associated chronic obstructive pulmonary disease (COPD) - underappreciated in the United States? Am J Respir Crit Care Med 2009; 179:A4742.
10. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in nonsmokers. Lancet 2009; 374:733-743.
11. Ranes J, Stoller JK. A review of alpha-1 antitrypsin deficiency. Semin Respir Crit Care Med 2005; 26:154-166.
12. Rasmussen F, Taylor DR, Flannery EM, et al. Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood. Am J Respir Crit Care Med 2002; 165:1480-1488.
13. Stern DA, Morgan WJ, Wright AL, et al. Poor airway function in early infancy and lung function by age 22 years: a nonselective longitudinal cohort study. Lancet 2007; 370:758-764.
14. Weiss ST, Ware JH. Overview of issues in the longitudinal analysis of respiratory data. Am J Respir Crit Care Med 1996; 154:S208-S211.
15. Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur Respir J 1999; 13:197-205.
16. Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004; 126:59-65.
17. Shirtcliffe P, Weatherall M, Marsh S, et al. COPD prevalence in a random population survey: a matter of definition. Eur Respir J 2007; 30:232-239.
18. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532-555.
19. Shirtcliffe P, Marsh S, Travers J, et al. Childhood asthma and GOLD-defined chronic obstructive pulmonary disease. Intern Med J 2012; 42:83-88.
20. Chinn S, Jarvis D, Melotti R, et al. Smoking cessation, lung function and weight gain: a follow-up study. Lancet 2005; 365:1629-1635.
21. Svanes C, Sunyer J, Plana E, et al. Early life origins of chronic obstructive pulmonary disease. Thorax 2010; 65:14-20.
22. Hirayama F, Lee AH. Association between childhood asthma and chronic obstructive pulmonary disease in later life. Asia Pac J Public Health 2012. [Epub ahead of print]
23. Morgan WJ, Stern DA, Sherrill DL, et al. Outcome of asthma and wheezing in the first 6 years of life. Follow-up through adolescence. Am J Respir Crit Care Med 2005; 172:1253-1258.
24. Sears MR, Greene JM, Willan AR, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003;349:1414-1422.
25. Jenkins MA, Hopper JL, Bowes G, et al. Factors in childhood as predictors of asthma in adult life. Br Med J 1994; 309:90-93.
26. Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. N Engl J Med 1995; 332:133-138.
27. Williams H, McNicol KN. Prevalence, natural history, and relationship of wheezy bronchitis and asthma in children. An epidemiological study. Br Med J 1969; 4:321-325.
28. McNicol KN, Williams HE. Spectrum of asthma in children. 1. Clinical and physiological components. Br Med J 1973; 4:7-11.
29. Martin AJ, McLennan LA, Landau LI, Phelan PD. The natural history of childhood asthma to adult life. Br Med J 1980; 280:1397-1446.
30. Oswald H, Phelan PD, Lanigan A, et al. Childhood asthma and lung function in mid-adult life. Pediatr Pulmonol 1997; 23:14-20.
31. Kelly WJ, Hudson I, Phelan PD, et al. Childhood asthma in adult life: a further study at 28 years of age. Br Med J 1987; 294:1059-1062.
32. Horak E, Lanigan A, Roberts M, et al. Longitudinal study of childhood wheezy bronchitis and asthma: outcome at age 42. Br Med J 2003; 326:422-423.
33. Tai A, Tran H, Roberts M, et al. Outcomes of childhood asthma to the age of 50 years. J Allergy Clin Immunol 2014; 133:1572-1578.
34. Tai A, Tran H, Roberts M, et al. The association between childhood asthma and adult chronic obstructive pulmonary disease. Thorax 2014; 69:805-810.
35. James AL, Palmer LJ, Kicic E, et al. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am J Respir Crit Care Med 2005; 171:109-114.
36. Apostol G, Jacobs DR, Tsai AW, et al. Early life factors contribute to the decrease in lung function between ages 18 and 40: the Coronary Artery Risk Development in Young Adults study. Am J Respir Crit Care Med 2002;166:166-172.
37. Nakano Y, Muller NL, King GG, et al. Quantitative assessment of airway remodeling using high-resolution CT. Chest 2002; 122:271-275.
38. McParland BE, Macklem PT, Pare PD. Airway wall remodelling: friend or foe? J Appl Physiol 2003; 95:426-434.
39. Bergeron C, Boulet LP. Structural changes in airway diseases: characteristics, mechanisms, consequences and pharmacologic modulation. Chest 2006; 129:1068-1087.
40. Bush A. How early do airway inflammation and remodeling occur? Allergol Int 2008; 57:11-19.
41. Payne DN, Qiu Y, Zhu J, et al. Airway inflammation in children with difficult asthma: relationships with airflow limitation and persistent symptoms. Thorax 2004; 59:862-869.
42. Payne DN, Rogers AV, Adelroth E, et al. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med 2003; 167:78-82.
43. Saglani S, Malmstrom K, Pelkonen AS, et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 2005; 171:722-727.
44. Saglani S, Payne DN, Zhu J, et al. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med 2007; 176:858-864.
45. Jongepier H, Boezen HM, Dijkstra A, et al. Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma. Clin Exp Allergy 2004; 34:757-760.
46. van Diemen CC, Postma DS, Vonk JM, et al. A disintegrin and metalloprotease33 polymorphisms and lung function decline in the general population. Am J Respir Crit Care Med 2005; 172:329-333.
47. Gosman MME, Boezen HM, van Diemen CC, et al. A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology. Thorax 2007; 62:242-247.
48. Gilliland FD, Gauderman J, Vora H, et al. Effects of glutathione-S-transferase M1, P1 and T1 on childhood lung function growth. Am J Respir Crit Care Med 2002; 166:710-716.
49. Kerkhof A, Marika Boezen H, Granell R, et al. Transient early wheeze and lung function in early childhood associated with chronic obstructive pulmonary disease genes. J Allergy Clin Immunol 2014; 133:68-76.
50. Pauwels RA, Buist SA, Calverley PMA, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276.
51. Calverley P, Burge PS, Spencer S, et al. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58:659-664.
52. Hardie J, Buist SA, Vollner W, et al. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002; 20:1117-1122.
53. Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003; 22:268-273.
54. Kohler D, Fischer J, Raschke JF, Schonhofer B. Usefulness of GOLD classification of COPD severity. Thorax 2003; 58:825.
55. Pellegrino R, Viegl G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26:948-968.
56. Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63:1046-1051.
57. Kasahara K, Shiba K, Pzawa T, et al. Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma. Thorax 2002; 57:242-246.
58. Saglani S, Papaioannou G, Khoo L, et al. Can HRCT be used as a marker of airway remodeling in children with difficult asthma? Respir Res 2006; 7:46-51.
59. Zar HJ, Hanslo D, Apolles P, et al. Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet 2005; 365:130-134.